Background illustration for clinical trials search

Paid Clinical Trials Chicago

Discover 2,382 paid clinical trials in Chicago, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors

for
Metastatic Pancreatic Neuroendocrine Tumor
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT06663072

Phase1, Recruiting

Non-invasive VNS for Parkinson's Gait

for
Parkinson's Disease
Location: Hines IL
Sponsor: VA Office of Research and Development

Sex: All

Age: 50 - 70+

Code: NCT06562569

Recruiting

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

for
Advanced Solid Tumor, Unresectable Solid Tumor,
Location: Chicago IL, Lexington KY, Nashville TN, Baltimore MD,
Sponsor: Clasp Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06778863

Phase1, Recruiting

PRE-ISPY Phase I/II Oncology Platform Program

for
HER2-positive Breast Cancer, Metastatic Cancer,
Location: Chicago IL, Orland Park IL, New Lenox IL,
Sponsor: QuantumLeap Healthcare Collaborative

Sex: All

Age: 18+

Code: NCT05868226

Phase1, Phase2, Recruiting

Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

for
Lymphoplasmacytic Lymphoma, Waldenstrom Macroglobulinemia
Location: Maywood IL, Danville IL, Urbana IL, Decatur IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04840602

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Spiritual Care Intervention in Adult Patients Diagnosed With Acute Leukemia

for
Leukemia
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT07405424

Recruiting

Personalized, Adaptive Treatment for Locally Advanced Head and Neck Cancer

for
HPV-Negative Squamous Cell Carcinoma
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT06005324

Phase1, Recruiting

CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL

for
Leukemia, Lymphoma
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT07294677

Phase1, Phase2, Recruiting

A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)

for
Acute Leukemia, Lymphoblastic Leukemia, Lymphoblastic Lymphoma
Location: Chicago IL, Rochester NY
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT06207123

Phase1, Phase2, Recruiting

ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML

for
B-cell Acute Lymphoblastic Leukemia,
Location: Chicago IL, Buffalo NY, Boston MA
Sponsor: Marlise Luskin, MD

Sex: All

Age: 18+

Code: NCT03595917

Phase1, Recruiting

Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy

for
Bladder Cancer
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 65+

Code: NCT06427824

Recruiting

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Location: Evanston IL, Detroit MI, Edgewood KY, Louisville KY,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06769698

Phase2, Recruiting

Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia

for
Schizophrenia
Location: Chicago IL, St Louis MO, Bentonville AR, Decatur GA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT07467993

Phase2, Recruiting

CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer

for
HER2-negative Breast Cancer, Metastatic Breast Cancer
Location: Chicago IL, Baltimore MD, Chapel Hill NC, Dallas TX,
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18 - 70+

Code: NCT05029999

Phase1, Recruiting

A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease

for
Acute Myeloid Leukemia,
Location: Chicago IL, Cincinnati OH, West Chester OH, Columbus OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT05886049

Phase1, Recruiting

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

for
Recurrent Endometrial Carcinoma,
Location: Chicago IL, Milwaukee WI, Iowa City IA, Columbus OH,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05950464

Phase1, Recruiting

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

for
Recurrent B-Cell Non-Hodgkin Lymphoma,
Location: Chicago IL, Orland Park IL, New Lenox IL, New York NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05272384

Phase1, Recruiting

Ivosidenib and Ruxolitinib in Patients With Advanced Myeloproliferative Neoplasms (MPNs) That Have an IDH1 Gene Mutation

for
Myeloproliferative Neoplasms
Location: Chicago IL, Milwaukee WI
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT06291987

Phase1, Recruiting

A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer

for
Breast Cancer
Location: Chicago IL, La Jolla CA, Sacramento CA
Sponsor: University of Chicago

Sex: Female

Age: 25+

Code: NCT03729115

Recruiting

A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors

for
Squamous Non-small-cell Lung Cancer,
Location: Chicago IL, Louisville KY, Fairfax VA, Hackensack NJ,
Sponsor: Alentis Therapeutics AG

Sex: All

Age: 18+

Code: NCT06747585

Phase1, Phase2, Recruiting

Chicago is a vital city for clinical research, offering a robust healthcare network and renowned medical research institutions. Major facilities such as The University of Chicago Medicine, Northwestern Medicine, and Rush University Medical Center are at the forefront of pioneering research across various fields, including cancer, cardiovascular health, and neurological disorders.

Why choose Chicago for clinical trials?

The city of Chicago offers many advantages for individuals considering participation in clinical trials. With a diverse and vibrant population, researchers benefit from the variety of participants, improving the reliability and applicability of research findings across different demographics.

By opting to participate in a clinical trial in Chicago, individuals not only gain access to cutting-edge therapies and treatments but also contribute to vital medical research. This collaborative effort is supported by a robust clinical research infrastructure, ensuring participants receive high-quality care and attention while playing a crucial role in shaping the future of healthcare.

Common conditions studied in Chicago

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Chicago